Condition
Meningo-encephalitis
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed2
Unknown2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03226379Not ApplicableCompleted
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
NCT02207647TerminatedPrimary
Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients
NCT04946682Not ApplicableUnknown
Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment
NCT03112031Phase 2Completed
Treatment With Tamoxifen in Cryptococcal Meningitis
NCT02868593Not ApplicableUnknown
Etiology of Orphan Community-based Meningitis and Meningo-encephalitis.
Showing all 5 trials